ERIC MILLER PROFILE Strong track record in traditional US commercial operations as well as complex marketing environments (global, alliance management, and orphan drug). Experience includes strategic planning for assets in mid and late-stage development, tactical support of established blockbuster brand, commercial operations and market expansion planning for injectable specialty biologic, and EU launch of first-to-market biotech device. Record of effective interaction with prominent thought leaders, advocacy groups, sales forces, and affiliates. WORK EXPERIENCE 5/2007 – Present Optio Consulting, LLC LLC Founder - Biotech Marketing Consultant San Francisco, CA 12/2005 – 4/2007 InterMune Corp. Brisbane, CA Senior Director, Commercial Operations Directed US commercial team preparing for the launch of two phase III products (biologic and small molecule) in pulmonary/critical care market and supporting orphan drug for primary immune disorder. Commercial team responsible for marketing, market research, analytics, revenue/P&L, advocacy group relations, thought leader development, national congress activity, and specialty pharmacy operations. Led commercial/marketing team to achieve national-level awards for advertorial and national congress messages as well as patient materials. Initiated and led thought leader advisor and advocacy relationship program and nationallevel meetings to obtain feedback on commercial plans and support for market messages. 7/2004 – 12/2005 Director, Pulmonary and CGD Marketing Led CGD (primary immune deficiency) marketing, managed partnership with Baxter Healthcare for ATT biologic co-promotion, and conducted pulmonary market planning. Developed first corporate strategic marketing plan for pulmonary/critical care market including health economics and corporate accounts/access and reimbursement planning. Created sales force materials, POA, and conducted training for 79 US representatives. 8/2002 – 7/2004 Cerus Corp. Concord, CA; Brussels and Madrid Associate Director, Marketing Conducted US product planning and supported a global corporate partnership by guiding EU commercialization of a DNA/RNA cross-linking pathogen safeguard technology for blood products. Product combines pharmaceutical, biologic, and device technology. Represented Cerus in eleven-month assignment as marketing/alliance manager at Baxter Healthcare EU headquarters to develop launch tactics and EU sales force operations. Managed multi-disciplinary team in the creation of target product profile for pathogen inactivation disposable/device in development for blood plasma market. SAN FRANCISCO, CALIFORNIA MOBILE: (925) 324-5527, EMAIL: EMILLER1@GMAIL.COM ERIC MILLER (page 2) 6/2000 – 7/2002 Eli Lilly and Company Indianapolis, IN Marketing Associate II, New Product Planning Conducted strategic global market planning for two compounds (phase II & III). Performed global market segmentation, selected target markets, and positioned both compounds. Led a broadly skilled cross-functional team to author two comprehensive annual plans. Market planning earned prestigious 2001 Lilly Individual Leadership Award – only five recipients from among all NPP, product, and brand team marketers company-wide. Executed a six-week launch readiness and portfolio review of the German Affiliate that shifted over $10 million to more profitable products. Recognized for, “valuable in-depth analysis and quality presentations in a high-workload, high-pressure, deadline-driven environment.” 12/1998 – 6/2000 Marketing Associate, Prozac Product Team (Brand Management) Coordinated global marketing communications for the largest blockbuster product in the company portfolio. Oversaw EU public relations and US direct-to-patient internet marketing. Pioneered Internet marketing for Lilly as sole driver of consumer marketing/research during the development of www.prozac.com. “Datamonitor considers Eli Lilly’s www.prozac.com site to be the best provider of interactive consumer services among the CNS sites we surveyed.”(8/2000) Received team leader’s award for overhauling public relations for the EU. “Eric improved PR operations with the global PR agency to the best level in the three year relationship with Lilly.” 7/1996 – 12/1998 Sales Representative Atlanta, GA Psychiatry and primary care territory. “Eric was the catalyst that turned around a traditionally lowperforming Lilly territory in Atlanta (bottom five percent) and drove it to the top five percent in the nation.” 4/1993 – 7/1996 SmithKline Beecham (GSK) Columbia, SC Senior Sales Representative Promoted primarily CNS products in a mixed hospital/specialist urban/rural territory. 11/1992 – 4/1993 Ciba Geigy (Novartis) Lynchburg, VA Sales Representative Sold NSAIDs, CV drugs, and HRT to primary care physicians and specialists. 9/1987 – 5/1992 United States Army Germany and US Locations Military Officer (Captain) Successfully led organizations of up to 190 men and women to achieve the rank of Captain. EDUCATION Prof. Sequence, Biotechnology Business & Marketing MS, Business Administration (MBA) BA, Gov’t & Int’l Relations (honors) UC Berkeley, 2006 Boston University, 1991 Univ. of Notre Dame, 1987 SAN FRANCISCO, CALIFORNIA MOBILE: (925) 324-5527, EMAIL: EMILLER1@GMAIL.COM
© Copyright 2024